Victory Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,092,559
Closed -$6.05M – 2795
2022
Q2
$6.05M Sell
1,092,559
-48,445
-4% -$397K 0.01% 1206
2022
Q1
$16.8M Buy
1,141,004
+184,633
+19% +$2.47M 0.02% 951
2021
Q4
$15.1M Buy
956,371
+103,961
+12% +$2.5M 0.01% 1009
2021
Q3
$27.4M Buy
852,410
+112,951
+15% +$3.97M 0.03% 772
2021
Q2
$30.7M Sell
739,459
-38,805
-5% -$1.59M 0.03% 745
2021
Q1
$39.5M Buy
778,264
+470,571
+153% +$24.6M 0.04% 638
2020
Q4
$9.98M Hold
307,693
– – 0.01% 1104
2020
Q3
$3.68M Hold
307,693
– – ﹤0.01% 1262
2020
Q2
$4.07M Sell
307,693
-77,704
-20% -$1.01M 0.01% 1211
2020
Q1
$4.34M Buy
385,397
+77,704
+25% +$954K 0.01% 1123
2019
Q4
$3.81M Hold
307,693
– – ﹤0.01% 1281
2019
Q3
$1.72M Buy
+307,693
New +$3.67M ﹤0.01% 1515

Other funds holding DMTK

Victory Capital Management's DMTK Position: Q3 2022 in Review

Victory Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 1,092,559 shares — an estimated $6.05M sold.

Victory Capital Management first reported a position in DMTK in Q3 2019 and held it in 12 quarters. The position peaked at $39.5M in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • Victory Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Victory Capital Management sold 1,092,559 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $6.05M.
  • Victory Capital Management first reported a position in DermTech, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • Victory Capital Management's DermTech, Inc. Common Stock position peaked at $39.5M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Victory Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.